Ubs Oconnor LLC Novo Nordisk A S Call Options Transaction History

Ubs Oconnor LLC

  • $1.46 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $1.19 Million - $1.45 Million
-10,000 Reduced 28.57%
25,000 $2.98 Million
Q2 2024

Aug 14, 2024
SELL
$122.71 - $146.91 $1.23 Million - $1.47 Million
-10,000 Reduced 22.22%
35,000 $5 Million
Q1 2024

May 15, 2024
BUY
$102.11 - $135.92 $4.59 Million - $6.12 Million
45,000 New
45,000 $5.78 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $1.82 Million - $3.99 Million
20,000 New
20,000 $1.82 Million

Others Institutions Holding NVO

# of Institutions
1,911
Shares Held
318M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $182B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email